Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Acosta

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|November 5, 2025
CD39 is an antibody-secreting B-cell marker that modulates germinal center and antibody responses during infectionLaura Almada, Yamila N Gazzoni, Cristian G Beccaria, et al.
Allergologia Et Immunopathologia|April 4, 2019
Youth tobacco use in Latin America: What is the real extent of the problem?M Urrutia-Pereira, D Solé, H J Chong Neto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Inhibitory Receptor Expression on T Cells as a Marker of Disease Activity and Target to Regulate Effector Cellular Responses in Rheumatoid ArthritisLuisina I Onofrio, Estefania R Zacca, Paola Ferrero, et al.
Nature Immunology|April 9, 2013
Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cellsDaniela A Bermejo, Shaun W Jackson, Melisa Gorosito-Serran, et al.
Frontiers in Immunology|October 27, 2018
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During <i>Trypanosoma cruzi</i> InfectionJimena Tosello Boari, Cintia L Araujo Furlan, Facundo Fiocca Vernengo, et al.
Oncoimmunology|October 9, 2023
Interleukin-17 signaling influences CD8<sup>+</sup> T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cellsConstanza Rodriguez, Cintia L Araujo Furlan, Jimena Tosello Boari, et al.
Frontiers in Immunology|February 11, 2026
Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progressionCarolina Abrate, Valentina Brunotto, Sabrina N Bossio, et al.
Oncoimmunology|May 12, 2025
CD8<sup>+</sup> T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevanceCarolina Abrate, Fernando P Canale, Sabrina N Bossio, et al.
Plos Pathogens|January 30, 2025
Dynamics of tissue repair regulatory T cells and damage in acute Trypanosoma cruzi infectionSantiago Boccardo, Constanza Rodriguez, Camila M S Gimenez, et al.
Frontiers in Immunology|December 30, 2022
Dynamics of circulating follicular helper T cell subsets and follicular regulatory T cells in rheumatoid arthritis patients according to HLA-DRB1 locusPaola V Ferrero, Luisina I Onofrio, Cristina Del Valle Acosta, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|November 5, 2025
CD39 is an antibody-secreting B-cell marker that modulates germinal center and antibody responses during infectionLaura Almada, Yamila N Gazzoni, Cristian G Beccaria, et al.
Allergologia Et Immunopathologia|April 4, 2019
Youth tobacco use in Latin America: What is the real extent of the problem?M Urrutia-Pereira, D Solé, H J Chong Neto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Inhibitory Receptor Expression on T Cells as a Marker of Disease Activity and Target to Regulate Effector Cellular Responses in Rheumatoid ArthritisLuisina I Onofrio, Estefania R Zacca, Paola Ferrero, et al.
Nature Immunology|April 9, 2013
Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cellsDaniela A Bermejo, Shaun W Jackson, Melisa Gorosito-Serran, et al.
Frontiers in Immunology|October 27, 2018
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During <i>Trypanosoma cruzi</i> InfectionJimena Tosello Boari, Cintia L Araujo Furlan, Facundo Fiocca Vernengo, et al.
Oncoimmunology|October 9, 2023
Interleukin-17 signaling influences CD8<sup>+</sup> T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cellsConstanza Rodriguez, Cintia L Araujo Furlan, Jimena Tosello Boari, et al.
Frontiers in Immunology|February 11, 2026
Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progressionCarolina Abrate, Valentina Brunotto, Sabrina N Bossio, et al.
Oncoimmunology|May 12, 2025
CD8<sup>+</sup> T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevanceCarolina Abrate, Fernando P Canale, Sabrina N Bossio, et al.
Plos Pathogens|January 30, 2025
Dynamics of tissue repair regulatory T cells and damage in acute Trypanosoma cruzi infectionSantiago Boccardo, Constanza Rodriguez, Camila M S Gimenez, et al.
Frontiers in Immunology|December 30, 2022
Dynamics of circulating follicular helper T cell subsets and follicular regulatory T cells in rheumatoid arthritis patients according to HLA-DRB1 locusPaola V Ferrero, Luisina I Onofrio, Cristina Del Valle Acosta, et al.
Pageof 7